<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Cytarabin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:49 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Cytarabin_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Cytarabin_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Cytarabin_files/filelist.xml">
<title>CYTARABIN </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>lylv</o:LastAuthor>
  <o:Revision>6</o:Revision>
  <o:TotalTime>1</o:TotalTime>
  <o:Created>2006-08-08T14:03:00Z</o:Created>
  <o:LastSaved>2006-08-09T05:21:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>1784</o:Words>
  <o:Characters>10171</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>84</o:Lines>
  <o:Paragraphs>23</o:Paragraphs>
  <o:CharactersWithSpaces>11932</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>CYTARABIN<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'><o:p>&nbsp;</o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Tên chung qu&#7889;c t&#7871;:</span></b><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'> Cytarabine. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Mã ATC: </span></b><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>L01B C01.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Lo&#7841;i thu&#7889;c:</span></b><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'> Ch&#7845;t &#273;&#7897;c t&#7871;
bào, ch&#7845;t ch&#7889;ng chuy&#7875;n hóa, ch&#7889;ng ung th&#432;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>D&#7841;ng thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>L&#7885; ch&#7913;a 100 mg, 500 mg, 1 g ho&#7863;c
2 g b&#7897;t &#273;ông khô cytarabin &#273;ã ti&#7879;t khu&#7849;n &#273;&#7875;
pha tiêm. N&#432;&#7899;c c&#7845;t pha tiêm, dung d&#7883;ch natri clorid 0,9%
ho&#7863;c dextrose 5% &#273;&#432;&#7907;c dùng pha tiêm.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>D&#432;&#7907;c lý và c&#417; ch&#7871; tác d&#7909;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Cytarabin (Ara - C), ch&#7845;t t&#432;&#417;ng t&#7921;
desoxycytosin nucleosid là m&#7897;t ch&#7845;t ch&#7889;ng chuy&#7875;n hóa.
Cytarabin có tác d&#7909;ng hóa tr&#7883; li&#7879;u ch&#7889;ng ung th&#432;
thông qua c&#417; ch&#7871; &#273;&#7863;c hi&#7879;u &#273;&#7889;i v&#7899;i
pha S c&#7911;a quá trình phân chia t&#7871; bào ho&#7841;t &#273;&#7897;ng
(không có t<span style='letter-spacing:-.1pt'>ác d&#7909;ng trên pha ngh&#7881;)
và &#7913;c ch&#7871; t&#7893;ng h&#7907;p DNA kèm theo tác d&#7909;ng kìm hãm
ho&#7863;c di&#7879;t t&#7871; bào ung th&#432;. Thu&#7889;c có tác d&#7909;ng
r&#7845;t ít trên RNA và quá trình t&#7893;ng h&#7907;p protein. Không th&#7845;y
có hi&#7879;n t&#432;&#7907;ng kháng chéo gi&#7919;a cytarabin và các thu&#7889;c
ch&#7889;ng ung th&#432; khác. Cytarabin li&#7873;u cao &#273;&#432;&#7907;c
dùng &#273;&#7875; &#273;i&#7873;u tr&#7883; b&#7879;nh b&#7841;ch c&#7847;u
khi dùng li&#7873;u bình th&#432;&#7901;ng &#273;ã có tình tr&#7841;ng kháng
thu&#7889;c t&#432;&#417;ng &#273;&#7889;i.</span><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Cytarabin không có tác d&#7909;ng qua
&#273;&#432;&#7901;ng u&#7889;ng, ch&#7881; d&#432;&#7899;i 20% li&#7873;u
&#273;&#432;&#7907;c h&#7845;p thu qua &#273;&#432;&#7901;ng tiêu hóa. Sau khi
gia nh&#7853;p vào t&#7871; bào b&#7879;nh b&#7841;ch c&#7847;u, cytarabin
&#273;&#432;&#7907;c phosphoryl hóa t&#7841;o thành d&#7841;ng ho&#7841;t
&#273;&#7897;ng cytarabin triphosphat, là ch&#7845;t &#7913;c ch&#7871; DNA
polymerase. Hi&#7879;u qu&#7843; lâm sàng sau khi tiêm d&#432;&#7899;i da hay
truy&#7873;n t&#297;nh m&#7841;ch liên t&#7909;c t&#7887; ra t&#7889;t h&#417;n
so v&#7899;i cách tiêm m&#7897;t l&#432;&#7907;ng l&#7899;n vào t&#297;nh m&#7841;ch.
Nguyên nhân có l&#7869; là vì ph&#7847;n l&#7899;n thu&#7889;c ch&#432;a k&#7883;p
tác d&#7909;ng lên t&#7871; bào ung th&#432; trong máu &#273;ã b&#7883; phân b&#7889;
r&#7845;t nhanh ra ngoài vòng tu&#7847;n hoàn ngay sau khi tiêm nhanh vào t&#297;nh
m&#7841;ch.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Cytarabin có t&#7927; l&#7879; g&#7855;n protein
kho&#7843;ng 15%, th&#7875; tích phân b&#7889; kho&#7843;ng 0,7 lít/kg thân tr&#7885;ng
và &#273;&#7897; thanh th&#7843;i toàn ph&#7847;n kho&#7843;ng 40 ml/phút/kg.
Sau khi tiêm t&#297;nh m&#7841;ch, cytarabin &#273;&#432;&#7907;c chuy&#7875;n
hóa thành uracil arabinosid (Ara - U) ch&#7911; y&#7871;u d&#432;&#7899;i tác d&#7909;ng
c&#7911;a các enzym kh&#7917; amin có &#7903; gan, ru&#7897;t và b&#7841;ch c&#7847;u.
N&#7917;a &#273;&#7901;i ban &#273;&#7847;u kho&#7843;ng 10 phút và n&#7917;a
&#273;&#7901;i th&#7843;i tr&#7915; c&#7911;a thu&#7889;c trong huy&#7871;t
t&#432;&#417;ng trung bình 1,5 gi&#7901;. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Trong vòng 24 gi&#7901;, sau khi tiêm t&#297;nh m&#7841;ch,
ph&#7847;n l&#7899;n li&#7873;u thu&#7889;c &#273;&#432;&#7907;c bài xu&#7845;t
qua n&#432;&#7899;c ti&#7875;u, ch&#7911; y&#7871;u d&#432;&#7899;i d&#7841;ng
ch&#7845;t chuy&#7875;n hóa không ho&#7841;t tính và kho&#7843;ng 10% d&#432;&#7899;i
d&#7841;ng cytarabin không b&#7883; chuy&#7875;n hóa.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Sau khi tiêm t&#297;nh m&#7841;ch, cytarabin qua
hàng rào máu - não không nhi&#7873;u, nh&#432;ng vì ho&#7841;t tính deaminase
trong d&#7883;ch não t&#7911;y th&#7845;p nên n&#7891;ng &#273;&#7897; thu&#7889;c
&#273;&#7841;t &#273;&#432;&#7907;c sau khi tiêm truy&#7873;n t&#297;nh m&#7841;ch
ch&#7853;m ho&#7863;c tiêm vào &#7889;ng s&#7889;ng &#273;&#432;&#7907;c duy
trì lâu h&#417;n trong d&#7883;ch não t&#7911;y so v&#7899;i huy&#7871;t
t&#432;&#417;ng (n&#7917;a &#273;&#7901;i kho&#7843;ng 2 gi&#7901; sau khi tiêm
&#7889;ng s&#7889;ng). N&#7891;ng &#273;&#7897; thu&#7889;c trong d&#7883;ch
não t&#7911;y &#273;&#7841;t &#273;&#7871;n 50% n&#7891;ng &#273;&#7897; &#7893;n
&#273;&#7883;nh trong huy&#7871;t t&#432;&#417;ng sau khi tiêm truy&#7873;n
liên t&#7909;c. <o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Cytarabin, ph&#7889;i h&#7907;p v&#7899;i m&#7897;t
s&#7889; thu&#7889;c ch&#7889;ng ung th&#432; khác nh&#432; thioguanin và
doxorubicin hay daunorubicin, &#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh ch&#7911;
y&#7871;u &#273;&#7875; &#273;i&#7873;u tr&#7883; b&#7879;nh b&#7841;ch c&#7847;u
c&#7845;p th&#7875; t&#7911;y &#7903; ng&#432;&#7901;i l&#7899;n và tr&#7867;
em. Thu&#7889;c c&#361;ng &#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh cho
các b&#7879;nh b&#7841;ch c&#7847;u c&#7845;p khác (b&#7879;nh b&#7841;ch c&#7847;u
c&#7845;p dòng lympho bào và giai &#273;o&#7841;n c&#7845;p c&#7911;a b&#7879;nh
b&#7841;ch c&#7847;u m&#7841;n th&#7875; t&#7911;y). Tiêm t&#7911;y s&#7889;ng
&#273;&#432;&#7907;c dùng &#273;&#7875; phòng và &#273;i&#7873;u tr&#7883; b&#7879;nh
b&#7841;ch c&#7847;u màng não. Li&#7873;u cao &#273;&#432;&#7907;c ch&#7881;
&#273;&#7883;nh &#273;&#7875; &#273;i&#7873;u tr&#7883; m&#7897;t s&#7889;
tr&#432;&#7901;ng h&#7907;p &#273;&#7863;c bi&#7879;t b&#7879;nh b&#7841;ch c&#7847;u
kháng thu&#7889;c v&#7899;i li&#7873;u thông th&#432;&#7901;ng.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ð&#7889;i v&#7899;i nh&#7919;ng ng&#432;&#7901;i
b&#7879;nh m&#7851;n c&#7843;m v&#7899;i các ch&#7871; ph&#7849;m ch&#7913;a
cytarabin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt;mso-ansi-language:DE'>Cytarabin là m&#7897;t thu&#7889;c
&#7913;c ch&#7871; m&#7841;nh t&#7911;y x&#432;&#417;ng, vì v&#7853;y, c&#7847;n
th&#7853;n tr&#7885;ng &#273;&#7889;i v&#7899;i nh&#7919;ng ng&#432;&#7901;i b&#7879;nh
b&#7883; suy t&#7911;y t&#7915; tr&#432;&#7899;c do thu&#7889;c. Ng&#432;&#7901;i
b&#7879;nh dùng cytarabin ph&#7843;i &#273;&#432;&#7907;c theo dõi ch&#7863;t
ch&#7869;, &#273;&#7891;ng th&#7901;i c&#7847;n &#273;&#432;&#7907;c ki&#7875;m
tra s&#7889; l&#432;&#7907;ng b&#7841;ch c&#7847;u và ti&#7875;u c&#7847;u hàng
ngày trong th&#7901;i gian &#273;i&#7873;u tr&#7883;. Sau khi các t&#7871; bào
non &#273;ã h&#7871;t &#7903; máu ngo&#7841;i vi, ph&#7843;i th&#432;&#7901;ng
xuyên làm t&#7911;y &#273;&#7891;. Ph&#7843;i chu&#7849;n b&#7883; s&#7861;n
ph&#432;&#417;ng ti&#7879;n &#273;&#7875; x&#7917; trí ngay các tai bi&#7871;n
có th&#7875; gây t&#7917; vong do suy t&#7911;y nh&#432; nhi&#7877;m khu&#7849;n
do gi&#7843;m b&#7841;ch c&#7847;u h&#7841;t và r&#7889;i lo&#7841;n nh&#7919;ng
y&#7871;u t&#7889; b&#7843;o v&#7879; khác, nh&#432; ch&#7843;y máu th&#7913;
phát do gi&#7843;m ti&#7875;u c&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Cytarabin có th&#7875; gây t&#259;ng acid uric
huy&#7871;t do h&#7911;y nhanh các t&#7871; bào ung th&#432;. Ph&#7843;i giám
sát acid uric - huy&#7871;t c&#7911;a ng&#432;&#7901;i b&#7879;nh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Gi&#7843;m li&#7873;u &#273;&#7889;i v&#7899;i
ng&#432;&#7901;i b&#7879;nh suy gi&#7843;m ch&#7913;c n&#259;ng gan.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Khi &#273;i&#7873;u tr&#7883; li&#7873;u cao,
nguy c&#417; xu&#7845;t hi&#7879;n tác d&#7909;ng ph&#7909; &#7903; th&#7847;n
kinh trung &#432;&#417;ng s&#7869; cao &#273;&#7889;i v&#7899;i nh&#7919;ng
ng&#432;&#7901;i b&#7879;nh &#273;ã &#273;i&#7873;u tr&#7883; t&#7915; tr&#432;&#7899;c
b&#7857;ng hóa ch&#7845;t qua tiêm &#7889;ng s&#7889;ng hay &#273;ã
&#273;&#432;&#7907;c chi&#7871;u x&#7841;; vì v&#7853;y không nên dùng quá li&#7873;u
2 g/m<sup>2</sup> m&#7895;i l&#7847;n, tiêm truy&#7873;n t&#7915; 1 &#273;&#7871;n
3 gi&#7901;, m&#7895;i l&#7847;n cách nhau 12 gi&#7901;, cho t&#7899;i 12 l&#7847;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>C&#7847;n tránh &#273;i&#7873;u tr&#7883;
cytarabin &#273;&#7891;ng th&#7901;i v&#7899;i truy&#7873;n b&#7841;ch c&#7847;u
h&#7841;t vì s&#7869; gây suy hô h&#7845;p n&#7863;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Không bao gi&#7901; &#273;&#432;&#7907;c dùng các
y&#7871;u t&#7889; t&#259;ng tr&#432;&#7903;ng nh&#432; GCSF (y&#7871;u t&#7889;
kích thích qu&#7847;n th&#7875; t&#7841;o b&#7841;ch c&#7847;u h&#7841;t)
tr&#432;&#7899;c hay trong th&#7901;i gian hóa tr&#7883; li&#7879;u ch&#7889;ng
ung th&#432; vì chúng kích thích tiêu di&#7879;t các t&#7871; bào &#7903;
ng&#432;&#7901;i b&#7879;nh. Do &#273;ó, ch&#7881; &#273;&#432;&#7907;c dùng
các y&#7871;u t&#7889; t&#259;ng tr&#432;&#7903;ng sau khi k&#7871;t thúc dùng
thu&#7889;c ch&#7889;ng ung th&#432;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Cytarabin r&#7845;t &#273;&#7897;c cho thai trong
3 tháng &#273;&#7847;u thai k&#7923;, vì v&#7853;y &#273;&#432;&#7907;c ch&#7881;
&#273;&#7883;nh nghiêm ng&#7863;t sau khi &#273;ã cân nh&#7855;c c&#7849;n th&#7853;n
gi&#7919;a l&#7907;i ích cho m&#7865; và nguy c&#417; &#273;&#7889;i v&#7899;i
con.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ch&#432;a có d&#7919; li&#7879;u tin c&#7853;y v&#7873;
l&#432;&#7907;ng cytarabin trong s&#7919;a m&#7865;. Tuy nhiên do &#273;&#7897;c
tính cao, không nên ti&#7871;p t&#7909;c cho con bú trong th&#7901;i gian
&#273;ang &#273;i&#7873;u tr&#7883; b&#7857;ng thu&#7889;c.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Tác d&#7909;ng không mong mu&#7889;n
(ADR)<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ph&#7843;n &#7913;ng không mong mu&#7889;n &#273;&#7889;i v&#7899;i
cytarabin ph&#7909; thu&#7897;c vào li&#7873;u l&#432;&#7907;ng. Th&#432;&#7901;ng
g&#7863;p nh&#7845;t là nh&#7919;ng ph&#7843;n &#7913;ng ph&#7909; &#273;&#432;&#7901;ng
tiêu hóa. Cytarabin c&#361;ng &#273;&#7897;c &#273;&#7889;i v&#7899;i t&#7911;y
x&#432;&#417;ng và gây ph&#7843;n &#7913;ng ph&#7909; v&#7873; huy&#7871;t h&#7885;c
t&#7911;y theo li&#7873;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#432;&#7901;ng g&#7863;p, ADR &gt;1/100<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Toàn thân: S&#7889;t.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Máu: Thi&#7871;u máu, b&#7879;nh nguyên h&#7891;ng c&#7847;u kh&#7893;ng
l&#7891;, gi&#7843;m b&#7841;ch c&#7847;u, gi&#7843;m ti&#7875;u c&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%;tab-stops:99.25pt'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: Bi&#7871;ng &#259;n, bu&#7891;n nôn, nôn.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%;tab-stops:99.25pt'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.2pt'>Da: Ban &#273;&#7887;, phát ban, ng&#7913;a, viêm
m&#7841;ch, r&#7909;ng tóc.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Gan: <span style='letter-spacing:-.2pt'>Nh&#7919;ng ph&#7843;n &#7913;ng
gan h&#7891;i ph&#7909;c, t&#259;ng các </span>transaminase.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Th&#7847;n kinh: Li&#7879;t 2 chi sau khi tiêm
vào &#7889;ng s&#7889;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>M&#7855;t: Viêm k&#7871;t m&#7841;c xu&#7845;t huy&#7871;t h&#7891;i
ph&#7909;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tim m&#7841;ch: Viêm t&#297;nh m&#7841;ch huy&#7871;t kh&#7889;i.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ít g&#7863;p, 1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Toàn thân: Ðau &#273;&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%;tab-stops:99.25pt'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#7847;n kinh trung &#432;&#417;ng: Viêm dây th&#7847;n kinh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>V&#7899;i li&#7873;u cao: H&#7897;i ch&#7913;ng ti&#7875;u não, thay
&#273;&#7893;i nhân cách, ng&#7911; gà và hôn mê. Co gi&#7853;t sau khi tiêm
vào &#7889;ng s&#7889;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>C&#417; x&#432;&#417;ng: Ðau c&#417;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tim m&#7841;ch: Viêm màng ngoài tim.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Da: Viêm mô d&#432;&#7899;i da &#7903; ch&#7895; tiêm, loét da, mày
&#273;ay.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>B&#7897; ph&#7853;n khác: Nhi&#7877;m khu&#7849;n huy&#7871;t, viêm ph&#7893;i.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Viêm t&#7909;y c&#7845;p &#273;ã &#273;&#432;&#7907;c ghi nh&#7853;n &#7903;
nh&#7919;ng ng&#432;&#7901;i b&#7879;nh &#273;ã &#273;&#432;&#7907;c &#273;i&#7873;u
tr&#7883; b&#7857;ng L - asparaginase tr&#432;&#7899;c khi dùng cytarabin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>H&#432;&#7899;ng d&#7851;n cách x&#7917;
trí ADR<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Quan tr&#7885;ng nh&#7845;t là x&#7917; lý v&#7845;n &#273;&#7873; suy
t&#7911;y</span></i><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'>: Các bi&#7879;n pháp tích c&#7921;c có
th&#7875; c&#7847;n thi&#7871;t &#273;&#7875; ch&#7889;ng nhi&#7877;m khu&#7849;n
và xu&#7845;t huy&#7871;t. Có th&#7875; c&#7847;n truy&#7873;n các s&#7843;n ph&#7849;m
c&#7911;a máu, truy&#7873;n ti&#7875;u c&#7847;u &#273;&#7875; tránh gi&#7843;m
ti&#7875;u c&#7847;u gây xu&#7845;t huy&#7871;t. Truy&#7873;n t&#297;nh m&#7841;ch
ch&#7853;m cytarabin s&#7869; gi&#7843;m b&#7899;t tác d&#7909;ng ph&#7909; &#7903;
&#273;&#432;&#7901;ng tiêu hóa. Nên dùng các glucocorticoid t&#7841;i ch&#7895;
&#273;&#7875; d&#7921; phòng ch&#7889;ng viêm k&#7871;t m&#7841;c xu&#7845;t
huy&#7871;t. Có th&#7875; dùng GCSF ho&#7863;c các y&#7871;u t&#7889; t&#259;ng
tr&#432;&#7903;ng khác nh&#432;ng ch&#7881; &#273;&#432;&#7907;c dùng sau khi k&#7871;t
thúc hóa tr&#7883; li&#7879;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ð&#7889;i v&#7899;i r&#7909;ng tóc</span></i><span style='font-size:
9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: Dùng
garô da &#273;&#7847;u, ch&#432;&#7901;m &#273;á l&#7841;nh &#273;&#7875; gi&#7843;m
n&#7891;ng &#273;&#7897; thu&#7889;c ch&#7889;ng ung th&#432; t&#7899;i m&#7913;c
t&#7889;i thi&#7875;u t&#7841;i da &#273;&#7847;u sau khi tiêm t&#297;nh m&#7841;ch.
Song ph&#432;&#417;ng pháp này có th&#7875; cho phép phát tri&#7875;n 1 &#7893;
t&#7909; t&#7853;p t&#7871; bào ung th&#432; và không nên áp d&#7909;ng trên nh&#7919;ng
ng&#432;&#7901;i b&#7879;nh b&#7883; b&#7879;nh b&#7841;ch c&#7847;u hay b&#7883;
nh&#7919;ng b&#7879;nh khác có t&#7871; bào ác tính l&#432;u hành trong máu.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Có th&#7875; tránh hi&#7879;n t&#432;&#7907;ng t&#259;ng acid uric</span></i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'> th&#7913; phát do phân gi&#7843;i kh&#7889;i u &#7903; nh&#7919;ng
ng&#432;&#7901;i b&#7879;nh b&#7883; b&#7879;nh b&#7841;ch c&#7847;u ho&#7863;c
u lympho b&#7857;ng cách thêm alopurinol vào phác &#273;&#7891; &#273;i&#7873;u
tr&#7883; và b&#7857;ng cách u&#7889;ng n&#432;&#7899;c &#273;&#7847;y &#273;&#7911;,
và n&#7871;u c&#7847;n, có th&#7875; ki&#7873;m hóa n&#432;&#7899;c ti&#7875;u.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u l&#432;&#7907;ng và
cách dùng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Có th&#7875; dùng cytarabin theo &#273;&#432;&#7901;ng tiêm t&#297;nh
m&#7841;ch, truy&#7873;n t&#297;nh m&#7841;ch liên t&#7909;c hay cách &#273;o&#7841;n,
tiêm d&#432;&#7899;i da ho&#7863;c tiêm trong &#7889;ng s&#7889;ng. Li&#7873;u
l&#432;&#7907;ng d&#7921;a vào &#273;áp &#7913;ng và dung n&#7841;p c&#7911;a t&#7915;ng
ng&#432;&#7901;i b&#7879;nh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Ði&#7873;u tr&#7883; c&#7843;m &#7913;ng &#273;&#7875;
thuyên gi&#7843;m b&#7879;nh b&#7841;ch c&#7847;u c&#7845;p &#7903; ng&#432;&#7901;i
l&#7899;n và tr&#7867; em: Li&#7873;u &#273;&#417;n tr&#7883; li&#7879;u
th&#432;&#7901;ng dùng: Truy&#7873;n liên t&#7909;c 6 mg/kg ho&#7863;c 200 mg/m<sup>2</sup>/ngày
trong 5 ngày, các &#273;&#7907;t &#273;i&#7873;u tr&#7883; cách nhau 2 tu&#7847;n.
Khi &#273;i&#7873;u tr&#7883; k&#7871;t h&#7907;p v&#7899;i thu&#7889;c khác,
có th&#7875; truy&#7873;n liên t&#7909;c 2 - 6 mg/kg/ngày (100 - 200 mg/m<sup>2</sup>/ngày)
ho&#7863;c chia thành 2 - 3 li&#7873;u tiêm hay truy&#7873;n t&#297;nh m&#7841;ch,
&#273;i&#7873;u tr&#7883; trong 5 - 10 ngày hay hàng ngày cho t&#7899;i khi b&#7879;nh
thuyên gi&#7843;m.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Li&#7873;u duy trì, m&#7863;c dù có thay &#273;&#7893;i, nh&#432;ng
th&#432;&#7901;ng tiêm b&#7855;p hay d&#432;&#7899;i da m&#7897;t li&#7873;u 1
- 1,5 mg/kg cách nhau 1 - 4 tu&#7847;n. Ho&#7863;c có th&#7875; m&#7895;i tháng
tiêm t&#297;nh m&#7841;ch hay truy&#7873;n liên t&#7909;c 1mg - 6 mg/kg ho&#7863;c
70 - 200 mg/m<sup>2</sup>/ngày trong 2 - 5 ngày.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ði&#7873;u tr&#7883; cytarabin li&#7873;u cao &#273;ã &#273;&#432;&#7907;c
áp d&#7909;ng &#273;&#7889;i v&#7899;i ng&#432;&#7901;i b&#7879;nh b&#7841;ch c&#7847;u
c&#7845;p khó ch&#7919;a ho&#7863;c u lympho khó ch&#7919;a. M&#7897;t phác
&#273;&#7891; hay dùng là 2 - 3 g/m<sup>2</sup> tiêm truy&#7873;n t&#297;nh m&#7841;ch
trong 1 - 3 gi&#7901;, cách 12 gi&#7901; m&#7897;t l&#7847;n truy&#7873;n,
trong t&#7915; 2 &#273;&#7871;n 6 ngày (ngh&#297;a là t&#7915; 4 - 12 li&#7873;u).
Dùng cytarabin li&#7873;u cao ph&#7843;i r&#7845;t c&#7849;n th&#7853;n và ph&#7843;i
do th&#7847;y thu&#7889;c quen dùng ph&#432;&#417;ng pháp này. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ði&#7873;u tr&#7883; b&#7879;nh b&#7841;ch c&#7847;u màng não: Li&#7873;u
dùng ph&#7893; bi&#7871;n là tiêm trong &#7889;ng s&#7889;ng 30 mg/m<sup>2</sup>
m&#7897;t l&#7847;n, cách nhau 4 ngày, cho t&#7899;i khi d&#7883;ch não t&#7911;y
tr&#7903; l&#7841;i bình th&#432;&#7901;ng thì b&#7893; sung thêm 1 li&#7873;u.
Ð&#7875; tiêm trong &#7889;ng s&#7889;ng không dùng dung d&#7883;ch pha loãng
ch&#7913;a benzyl - alcol.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Có th&#7875; không c&#7847;n ph&#7843;i gi&#7843;m li&#7873;u &#7903;
nh&#7919;ng ng&#432;&#7901;i b&#7879;nh b&#7883; gi&#7843;m ch&#7913;c
n&#259;ng th&#7853;n nh&#432;ng ph&#7843;i gi&#7843;m li&#7873;u &#273;&#7889;i
v&#7899;i ng&#432;&#7901;i b&#7879;nh suy gan.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Trong th&#7901;i gian &#273;i&#7873;u tr&#7883; c&#7847;n theo dõi s&#7889;
l&#432;&#7907;ng b&#7841;ch c&#7847;u và ti&#7875;u c&#7847;u. Nên ng&#7915;ng
thu&#7889;c n&#7871;u s&#7889; l&#432;&#7907;ng &#273;ó b&#7883; gi&#7843;m
nhanh ho&#7863;c gi&#7843;m t&#7899;i m&#7913;c quá th&#7845;p (d&#432;&#7899;i
1000/mm<sup>3</sup> &#273;&#7889;i v&#7899;i b&#7841;ch c&#7847;u &#273;a nhân <span
style='letter-spacing:-.1pt'>trung tính và d&#432;&#7899;i 50.000/mm<sup>3</sup>
&#273;&#7889;i v&#7899;i ti&#7875;u c&#7847;u).<o:p></o:p></span></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cách pha ch&#7871; và s&#7917; d&#7909;ng thu&#7889;c:</span></i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'> Ð&#7875; tiêm truy&#7873;n, cytarabin &#273;&#432;&#7907;c hòa trong
dung d&#7883;ch mu&#7889;i sinh lý (natri clorid 0,9%) ho&#7863;c trong dung d&#7883;ch
glucose (dung d&#7883;ch glucose 50 mg/ml). Dung d&#7883;ch tiêm truy&#7873;n
không bao gi&#7901; &#273;&#432;&#7907;c ch&#7913;a ch&#7845;t b&#7843;o qu&#7843;n
và do &#273;ó không bao gi&#7901; &#273;&#432;&#7907;c dùng dung d&#7883;ch có
benzyl - alcol. Hàm l&#432;&#7907;ng cytarabin cu&#7889;i cùng không
&#273;&#432;&#7907;c v&#432;&#7907;t quá 50 mg/ml dung d&#7883;ch truy&#7873;n.
Các dung d&#7883;ch thu&#7889;c không có ch&#7845;t b&#7843;o qu&#7843;n này ph&#7843;i
&#273;&#432;&#7907;c dùng ngay.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cytarabin không &#273;&#7897;c &#273;&#7889;i v&#7899;i mô, vì v&#7853;y
n&#7871;u l&#7905; tiêm ra ngoài m&#7841;ch s&#7869; không nguy hi&#7875;m và
không c&#7847;n ph&#7843;i x&#7917; lý.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Khi 2 hay nhi&#7873;u thu&#7889;c gây suy t&#7911;y (bao g&#7891;m c&#7843;
chi&#7871;u tia) dùng &#273;&#7891;ng th&#7901;i ho&#7863;c dùng liên ti&#7871;p
v&#7899;i cytarabin, có th&#7875; x&#7843;y ra hi&#7879;p &#273;&#7891;ng thu&#7889;c
gây suy t&#7911;y m&#7841;nh h&#417;n, do &#273;ó c&#7847;n gi&#7843;m li&#7873;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.2pt'>Có tr&#432;&#7901;ng h&#7907;p dùng &#273;&#7891;ng
th&#7901;i cyclophosphamid v&#7899;i cytarabin li&#7873;u cao &#273;&#7875; chu&#7849;n
b&#7883; ghép t&#7911;y &#273;ã gây t&#259;ng b&#7879;nh c&#417; tim d&#7851;n
&#273;&#7871;n t&#7917; vong.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>S&#7917; d&#7909;ng cytarabin 48 gi&#7901; tr&#432;&#7899;c ho&#7863;c
10 phút sau khi b&#7855;t &#273;&#7847;u &#273;i&#7873;u tr&#7883; b&#7857;ng
methotrexat có th&#7875; gây tác d&#7909;ng hi&#7879;p &#273;&#7891;ng, tuy
nhiên ch&#432;a có k&#7871;t lu&#7853;n ch&#7855;c ch&#7855;n và c&#7847;n ph&#7843;i
&#273;i&#7873;u ch&#7881;nh li&#7873;u d&#7921;a vào theo dõi th&#432;&#7901;ng
qui v&#7873; huy&#7871;t h&#7885;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Nên c&#7849;n th&#7853;n khi dùng cytarabin cùng v&#7899;i m&#7897;t
vaccin &#273;&#7863;c bi&#7879;t là v&#7899;i vaccin virus s&#7889;ng vì
cytarabin có th&#7875; làm suy gi&#7843;m các c&#417; ch&#7871; phòng v&#7879;
bình th&#432;&#7901;ng c&#7911;a c&#417; th&#7875; và s&#7869; làm gi&#7843;m
&#273;áp &#7913;ng c&#7911;a kháng th&#7875; &#7903; ng&#432;&#7901;i b&#7879;nh
&#273;&#7889;i v&#7899;i vaccin. Ng&#432;&#7901;i b&#7879;nh b&#7841;ch c&#7847;u
&#273;ã thuyên gi&#7843;m ch&#7881; nên tiêm ch&#7911;ng vaccin s&#7889;ng ít
nh&#7845;t 3 tháng sau &#273;&#7907;t &#273;i&#7873;u tr&#7883; hóa ch&#7845;t
l&#7847;n cu&#7889;i.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Cytarabin t&#432;&#417;ng tác v&#7899;i
gentamicin. Nghiên c&#7913;u trên nh&#7919;ng ng&#432;&#7901;i b&#7879;nh
&#273;ang dùng cytarabin và ph&#7843;i &#273;i&#7873;u tr&#7883; nhi&#7877;m
khu&#7849;n <i>K. pneumoniae</i> b&#7857;ng gentamicin cho th&#7845;y thi&#7871;u
s&#7921; &#273;áp &#7913;ng &#273;i&#7873;u tr&#7883; nhanh chóng và do &#273;ó
c&#7847;n</span><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'> ph&#7843;i &#273;ánh giá l&#7841;i hi&#7879;u
qu&#7843; c&#7911;a kháng sinh tr&#7883; li&#7879;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Trong khi &#273;i&#7873;u tr&#7883; v&#7899;i fluorocytosin, cytarabin
&#7913;c ch&#7871; tác d&#7909;ng c&#7911;a thu&#7889;c này. Có th&#7875; là do
&#7913;c ch&#7871; c&#7841;nh tranh h&#7845;p thu vì v&#7853;y có th&#7875; có &#7843;nh
h&#432;&#7903;ng &#273;&#7871;n chuy&#7875;n hóa c&#7911;a fluorocytosin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897; &#7893;n &#273;&#7883;nh
và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Các l&#7885; cytarabin 100 - 500 mg &#273;&#432;&#7907;c b&#7843;o qu&#7843;n
&#7903; nhi&#7879;t &#273;&#7897; phòng không quá 25<sup>0</sup>C. &#7902; 25<sup>0</sup>C
gi&#7919; &#273;&#432;&#7907;c ít nh&#7845;t 36 tháng. Dung d&#7883;ch &#273;ã
pha có th&#7875; b&#7843;o qu&#7843;n &#7903; nhi&#7879;t &#273;&#7897; phòng t&#7899;i
48 gi&#7901;. Dung d&#7883;ch ch&#7913;a 20 và 50 mg/ml cytarabin dùng &#273;&#7875;
tiêm trong &#7889;ng s&#7889;ng &#273;&#432;&#7907;c b&#7843;o qu&#7843;n trong
các b&#417;m tiêm b&#7857;ng plastic &#7903; 22,8 và -10<sup>o</sup>C, thu&#7889;c
không b&#7883; phân h&#7911;y trong th&#7901;i gian 1 tu&#7847;n b&#7843;o qu&#7843;n
&#7903; nh&#7919;ng nhi&#7879;t &#273;&#7897; này.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng k&#7925;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>M&#7863;c dù trong y v&#259;n &#273;ã ghi cytarabin t&#432;&#417;ng k&#7925;
v&#7899;i dung d&#7883;ch fluorouracil và methotrexat nh&#432;ng m&#7897;t s&#7889;
nghiên c&#7913;u cho th&#7845;y cytarabin v&#7851;n b&#7873;n v&#7919;ng trong
vài gi&#7901; khi hòa l&#7851;n v&#7899;i methotrexat.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Không có thu&#7889;c gi&#7843;i &#273;&#7897;c khi dùng quá li&#7873;u
cytarabin. Truy&#7873;n t&#297;nh m&#7841;ch 12 li&#7873;u, m&#7895;i li&#7873;u
4,5 g/m<sup>2</sup>, trong 1 gi&#7901; cách nhau 12 gi&#7901;, gây &#273;&#7897;c
quá m&#7913;c không h&#7891;i ph&#7909;c cho h&#7879; th&#7847;n kinh trung
&#432;&#417;ng và ch&#7871;t. Các li&#7873;u cao duy nh&#7845;t 3 g/m<sup>2</sup>
&#273;ã &#273;&#432;&#7907;c tiêm t&#297;nh m&#7841;ch nhanh không gây &#273;&#7897;c
rõ r&#7879;t.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ð<span style='letter-spacing:.1pt'>&#7875; x&#7917; lý tr&#432;&#7901;ng
h&#7907;p quá li&#7873;u và nhi&#7877;m &#273;&#7897;c cytarabin, c&#7847;n ph&#7843;i
ng&#7915;ng &#273;i&#7873;u tr&#7883;, sau &#273;ó gi&#7843;i quy&#7871;t v&#7845;n
&#273;&#7873; suy t&#7911;y bao g&#7891;m truy&#7873;n máu toàn ph&#7847;n hay
truy&#7873;n ti&#7875;u c&#7847;u và &#273;i&#7873;u tr&#7883; b&#7857;ng kháng
sinh.<o:p></o:p></span></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:.1pt'>Cytarabin có trong danh m&#7909;c thu&#7889;c thi&#7871;t
y&#7871;u Vi&#7879;t Nam ban hành l&#7847;n th&#7913; t&#432; n&#259;m 1999. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:.1pt'>Thu&#7889;c &#273;&#7897;c b&#7843;ng A.</span><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'><o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Cytarabin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:49 GMT -->
</html>
